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Abstract 
 
Background: The long-term health outcomes and costs of helicopter emergency 
medical services (HEMS) assistance remain uncertain. The aim of this study was to 
investigate the cost-effectiveness of HEMS assistance compared with emergency 
medical services (EMS). 
Methods: A prospective cohort study was performed at a level I trauma centre. 
Quality-of-life measurements were obtained at 2 years after trauma, using the 
EuroQol – Five Dimensions (EQ-5D) as generic measure to determine health status. 
Health outcomes and costs were combined into costs per quality-adjusted life year 
(QALY). 
Results: The study population receiving HEMS assistance was more severely injured 
than that receiving EMS assistance only. Over the 4-year study interval, HEMS 
assistance saved a total of 29 additional lives. No statistically significant differences 
in quality of life were found between assistance with HEMS or with EMS. Two years 
after trauma the mean EQ-5D utility score was 0.70 versus 0.71 respectively. The 
incremental cost–effectiveness ratio for HEMS versus EMS was €28 327 per QALY. 
The sensitivity analysis showed a cost–effectiveness ratio between €16 000 and 
€62 000. 
Conclusion: In the Netherlands, the costs of HEMS assistance per QALY remain 
below the acceptance threshold. HEMS should therefore be considered as cost-
effective. 
 
 A: Introduction 
In most Western countries, helicopter emergency medical services (HEMS) are 
available to provide on-scene assistance to trauma patients
1
. HEMS can be requested 
by the dispatch centre or by regular emergency medical services (EMS) already at the 
accident site. The type and quality of care provided by HEMS may differ depending 
on local (regional and national) circumstances, needs and appointments. Depending 
on these conditions, HEMS may be staffed by physicians, flight nurses or 
paramedics
2
. As these professionals have different levels of certification, they provide 
different therapeutic options to patients at the accident site. The utilization of HEMS 
may also differ as a result of topographical and infrastructural diversity (urban, rural 
or inaccessible areas)
3
. HEMS are used to cover long-distance patient contacts and to 
transport advanced life support to the scene of an accident, after which a patient is 
transported to hospital by ambulance or helicopter. Owing to limited conclusive 
literature, the health effects of HEMS remain uncertain. However, published reviews 
have reported positive effects of HEMS assistance on survival, as has also been 
observed in the Netherlands
4–8
. 
Another important question is the cost of this care. It is well known that 
prehospital trauma care provided by HEMS is relatively expensive. In an era where 
healthcare cost savings have a high priority for governments, expensive treatment 
modalities and health services are monitored carefully. 
Studies into the cost-effectiveness of HEMS are limited
4,8–10
. To date, only two 
studies on survival and quality of life (QoL) in combination with costs per quality-
adjusted life year (QALY) have been published
9,11
. These two studies reported costs 
per QALY for HEMS of between €7300 and €37 700 (US $9300–47 900)9,11. The use 
of costs per QALY as an outcome measure is important and allows comparison of the 
efficiency of different types of healthcare service with one another. It also may 
support decisions to restrict investment to services with costs per QALY below a 
predefined acceptance threshold. The acceptance of cost per QALY is, however, not 
an absolute figure. Policy-makers and healthcare economists have proposed that costs 
varying from €25 000 up to €75 000 (US $31 800–95 300) per QALY may be 
considered acceptable
12–14
. 
In 1995, when HEMS were introduced in the Netherlands, a cost–effectiveness 
study was undertaken
11
. The Dutch trauma system has since been developed and now 
covers the entire country
15
. The organization of the trauma system, as well as the level 
of training of HEMS physicians, nurses and the trauma centre doctors, has improved 
since then. In consequence, a well designed study was needed to measure the effects 
of HEMS on survival and QoL. This cost–effectiveness analysis is presented here. 
The study hypothesis was that the costs per QALY for HEMS in the Netherlands were 
below the acceptance threshold. 
 
+A: Methods 
For survival and cost calculations, data were collected from 1 January 2003 to 31 
December 2006. During this 4-year study period a prospective cohort study was 
conducted that included all consecutive patients with polytrauma aged over 13 years 
with an Injury Severity Score (ISS)
16
 greater than 15, who were admitted to the 
emergency department of a level I trauma centre. Patients identified as dead on arrival 
at the scene of the accident were excluded from the study. 
Data were extracted from the trauma registry, which includes the same variables 
as in the Major Trauma Outcome Study (MTOS) database
1
 (age, Glasgow Coma 
Scale (GCS)
17
 score, Revised Trauma Score (RTS)
18
, mechanism of trauma and 
details of injuries). Missing data were obtained from the original ambulance charts. 
All patients receiving on-scene EMS and HEMS assistance were included in the 
HEMS group. Patients treated only by EMS services were included in the EMS group. 
 
+B: Survival calculations 
Estimated survival was determined with the Trauma Injury Severity Score (TRISS) 
method, which includes the ‘predicted mortality’19. The TRISS (logistic regression-
based) method is the multivariable approach of choice
20
. The coefficients used in the 
TRISS model are derived from the MTOS
1
. To compare case mix between the regular 
MTOS population and this study population, the M statistic must be calculated. 
Although M does not follow a specific distribution, it is generally considered 
acceptable to apply the uncorrected TRISS when M is 0.88 or higher
21
. As the value 
of M in the authors’ population was 0.38, a custom-fitted regression model was used 
to calculate predicted survival. Construction of the logistic regression was analogous 
to the method described by Frankema and colleagues
7
. After evaluating variables for 
their contribution to the model, the following variables were finally included in the 
regression model: RTS – systolic blood pressure, RTS – respiratory rate, RTS – GCS, 
ISS
16
, mechanism of trauma, age, sex and type of care (HEMS or EMS). The 
performance of the regression model in terms of goodness of fit was tested with the 
Hosmer–Lemeshow (HL) statistic, and its discriminative value was assessed by 
calculating the area under the receiver operating characteristic (ROC) curve. The 
regression model was used to determine the number of lives saved by HEMS 
assistance. 
 +B: Quality-of-life measurements 
The EuroQol – Five Dimensions (EQ-5D) was used as a generic measure to determine 
health status 2 years after trauma. The EQ-5D is generally recommended for 
economic evaluation of trauma care at a consensus conference
22
. A domain-related 
scoring algorithm based on empirical valuations from the UK general population and 
subsequent statistical modelling is available, by means of which each health status 
description can be expressed as a utility score
23
. This summary score ranges on a scale 
from 1 to −0.059 (1 and 0 indicate full health and death respectively), and can be used 
to judge the relative quality of a health status compared with perfect health. Negative 
values for summary scores (−0.059) are possible because EQ-5D defines states worse 
than death, such as persistent vegetative health status
23
. Death was defined as within 
30 days of the trauma. At 24 months after trauma admission, all included survivors 
from 2003 until 2005 received a written questionnaire by post. If there was no 
response after 1 month, patients were telephoned in an attempt to increase 
participation. 
 
+B: Cost calculations 
Medical costs were calculated by multiplying the volumes of healthcare used with the 
corresponding unit prices in 2006. The costs per in-hospital patient-day (including 
intensive care stay), emergency department costs, operating costs, costs of 
diagnostics, and outpatient department visit costs were included in the direct medical 
cost calculations. Cost volumes were recorded with hospital information systems, and 
the patient questionnaire. The questionnaire also included questions relating to long-
term medical care (rehabilitation costs). In the Netherlands, a detailed ‘fee for service’ 
system is used for the remuneration of medical interventions and diagnostic 
procedures
24
, enabling calculation of micro-costs. Thus, medical costs were 
determined by multiplying the volumes of healthcare used per individual patient with 
the corresponding official Dutch unit prices for each diagnostic or therapeutic 
procedure. The cost of the HEMS assistance was based on the actual cost as found in 
the balance of payments of 2003 to 2006. 
 
+B: Cost–effectiveness analysis 
Cost-effectiveness was assessed by calculating the incremental cost–effectiveness 
ratio, defined by the difference in mean costs between the two prehospital emergency 
care approach strategies (HEMS and EMS) divided by the difference in average 
health effects. The effect is expressed as quality-adjusted life years (QALYs). A 
QALY takes into account the premature loss of life from death by using years of life 
lost, and the length of time without full health for non-fatal conditions as measured by 
years lived with disability. The QALY provides a means of combining the impact of 
fatal and non-fatal outcomes in a single measure. The incremental costs of HEMS 
consisted of the extra costs per HEMS-treated patient compared with patients in the 
EMS group. 
 
+B: Discounting 
It is generally accepted practice in economic evaluations to discount future costs and 
benefits arising from healthcare interventions to reflect individuals’ and society’s time 
preference
25
. To compare the benefits that occur over time, benefits occurring in 
future years must be adjusted to relate to the ‘present value’ in which the costs are 
spent. A discount rate of 1.5 per cent for the benefits was used, as recommended in 
the Dutch guidelines for economic evaluations in this study
26
. 
 
+B: Statistical analysis 
As discount rates vary over time and across countries, the effect of using different 
discount rates on the results obtained by sensitivity analysis was determined. An 
annual discount rate of 0 and 3.5 per cent for benefits was used because the rate of 3.5 
per cent was recommended by the National Institute for Health and Clinical 
Excellence. Statistical analyses were performed using SPSS
®
 version 12.0 (SPSS, 
Chicago, Illinois, USA). P<0.050 was considered statistically significant. 
 
+A: Results 
+B: Effect of helicopter emergency medical services assistance on survival 
During the 4-year study interval, 781 patients were admitted to the emergency 
department of a level I trauma centre. The majority of patients were men (72.6 per 
cent) and sustained blunt force trauma (91.3 per cent) (Table 1). Patients in the HEMS 
group were younger than those in the EMS group (median age 36 versus 43 years 
respectively), had more disturbed vital parameters (median GCS 3 versus 13; median 
RTS 8 versus 12) and were more severely injured (median ISS 29 versus 22). In the 
HEMS population, relatively more patients were artificially ventilated (49.7 versus 
14.0 per cent in the EMS group). The unadjusted mortality rate for the two groups 
was comparable (Table 1). 
The HL statistic showed that the regression model had an appropriate goodness of 
fit (R
2 
= 6, P = 0.650). The area under the ROC curve was 0.90, indicating excellent 
discriminative power. The survival analyses showed that that over the study period 
HEMS assistance saved a total of 29 additional lives. The TRISS method gave results 
comparable to those of the regression model used in this study (HEMS saved 27.5 
more lives than predicted by TRISS (Z = 4.47, P<0.001; W statistic = 8.86)), although 
with an M value of 0.38 no reliable conclusions could be drawn based on the TRISS 
method. The results of the regression model were therefore used for subsequent 
calculations. 
 
+B: Quality of life 
Of the 781 patients with polytrauma (ISS above 15), 654 (from 2003 to 2005) were 
sent a written questionnaire 24 months after the trauma. Of these, 454 patients had 
survived their injuries. Follow-up data for 255 patients were obtained (response rate 
56.2 per cent). Of the 199 patients who did not participate, 194 were untraceable, one 
could not be included because of communication difficulties, and four were unwilling 
to participate. The health status of patients who were finally included showed an EQ-
5D summary score of 0.70 2 years after trauma; this was far below that of the Dutch 
general population norm of 0.87
27
. No statistically significant differences in quality of 
life were found between patients assisted by HEMS and those assisted by EMS. Two 
years after trauma, the mean EQ-5D utility score was 0.70 versus 0.71 respectively, 
and the prevalence of physical and physiological limitations for the total patient 
population was high for all EQ-5D dimensions (mobility, 43.9 per cent; self-care, 18.9 
per cent; usual activities, 54.6 per cent; pain and discomfort, 61.4 per cent; anxiety 
and depression, 40.2 per cent) (Fig. 1). There were no significant differences between 
the two groups for any of the separate health domains measured with the EQ-5D. On 
some dimensions (mobility, self-care and usual activities) the prevalence of 
limitations was slightly lower for HEMS than for EMS assistance, but for the others 
(pain, anxiety/depression and emotion) the reverse was found. 
 
+B: Costs 
The average medical treatment costs for HEMS-assisted patients were €39 200 (Table 
2). The main costs related to length of hospital admission (€10 300) and intensive care 
stay (€16 100). The average costs for an ambulance-assisted patient were significantly 
lower at €34 500 (P=0.016). This difference was due mainly to costs for intensive 
care and diagnostic modalities, resulting in incremental costs for medical care of 
€4700 per HEMS-assisted patient. 
 
+B: Cost–effectiveness analysis 
The costs for the 4 years of HEMS assistance totalled €11 314 972 (€5 574 878 for 
personnel and €5 740 094 for material costs). The total incremental costs of medical 
were €987 000 (€4700 for each of the 210 surviving HEMS patients over 4 years). 
The total cost for HEMS assistance was calculated as €12 301 972 (actual HEMS cost 
of €11 314 972 plus the total incremental cost of €987 000). Based on these 
calculations, when using the recommended discount rate of 1.5 per cent, the costs for 
HEMS were €28 327 per QALY (Table 3). In a sensitivity analysis performed to test 
the effect of using different discount rates, the costs per QALY for HEMS when using 
a discount rate of 0.0 or 3.5 per cent were €16 000 and €62 000 respectively. 
 
+A: Discussion 
HEMS assistance is effective in saving the lives of moderately and severely injured 
trauma patients. The study population receiving HEMS assistance was more severely 
injured than those receiving only EMS assistance. The incremental costs for 
intramural care were €4700 for HEMS-treated patients, determined mainly by the 
costs of intensive care stay and diagnostic modalities used. Over the study interval, 
HEMS assistance saved a total of 29 additional lives. No statistically significant 
differences in quality of life were found between HEMS and EMS-assisted patients. 
Two years after trauma, the mean EQ-5D utility score was 0.70 versus 0.71 
respectively. The incremental cost–effectiveness ratio for the use of HEMS rather 
than EMS was €28 327 per QALY. 
Functional outcome and quality of life of survivors of severe injury do not return 
to normal 2 years after trauma. The prevalence of specific limitations in this 
population is high (40–61 per cent), and differences between HEMS- and EMS-
assisted patients in the EQ-5D summary score and all specific health dimensions were 
small, non-significant and inconsistent. In previous studies
28,29
, determinants of long-
term functional consequences of major trauma have demonstrated good performance 
of EQ-5D in survivors of major trauma, in terms of discriminative power and 
sensitivity to change. As well validated instruments were used in the present study, 
the reported high prevalence of problems is a good reflection of the health situation of 
patients with major trauma. 
The sensitivity analysis showed that the choice of discount rate greatly influenced 
the findings of the cost–effectiveness analysis. Use of a discount rate of 0 versus 3.5 
per cent resulted in a cost–effectiveness ratio of €16 000 and €62 000 respectively. 
Both of these values are below the acceptance threshold of €75 000 per QALY12–14. 
To put these results of costs per QALY into greater perspective, comparison can be 
made with the costs of other treatment modalities regularly performed in the 
Netherlands. For example, for liver, heart and lung transplantation, the costs per 
QALY are €35 100, €36 800 and €79 500 respectively30. 
The relatively low response rate of 56 per cent could be regarded as a limitation of 
the present study and may have affected the costs per QALY. Much of the study 
population was untraceable because the patients were not living in the Netherlands 
and were consequently lost to follow-up. 
When the health status of the study population at 2 years after trauma was 
compared with quality-of-life measurements at 1 year in a comparable cohort during 
the same study interval, QoL at 2 years was slightly lower than that reported at 1 year 
(mean EQ-5D utility score 70 versus 73). This finding has been reported previously
31
. 
A possible explanation is that patients with disturbed health status are more likely to 
participate in QoL measurements. In this case, the low response rate in the present 
study could have influenced the QoL score, and the actual health status of the whole 
study population might have been higher than measured. A better average health 
status would have resulted in lower costs per QALY. 
With calculated incremental costs for medical care of €4700 per HEMS-assisted 
patient, the costs per QALY for HEMS in the Netherlands remain below the 
acceptance threshold. Thus, HEMS should be considered as cost effective. 
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Fig. 1 Prevalence of physical and physiological limitations (moderate or severe) in the 
each of the EuroQol – Five Dimensions health domains 2 years after trauma 
according to type of prehospital trauma care: helicopter emergency medical services 
(HEMS) versus emergency medical services (EMS). There were no statistically 
significant differences between the groups (χ2 test) 
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Table 1 Characteristics of patients assisted by helicopter emergency medical services 
or emergency medical services 
 Overall 
(n=781) 
HEMS 
(n=310) 
EMS 
(n=471) 
P 
Men* 567 (72.6) 233 (75.2) 334 (70.9) n.s.† 
Age (years) 41 (25–62) 36 (23–57) 43 (27–66) 0.008‡ 
Blunt trauma* 713 (91.3) 289 (93.2) 424 (90.0) n.s.† 
GCS score 11 (3–15) 3 (3–15) 13 (5–15) < 0.001‡ 
Revised Trauma Score 11 (8–12) 8 (8–12) 12 (9–12) < 0.001‡ 
Injury Severity Score 25 (18–33) 29 (22–38) 22 (17–26) < 0.001‡ 
Prehospital intubation* 220 (28.2) 154 (49.7) 66 (14.0) < 0.001† 
Mortality* 228 (29.2) 100 (32.3) 128 (27.2) n.s.† 
Values are median (interquartile range) unless indicated otherwise; *values in 
parentheses are percentages. GCS, Glasgow Coma Scale; n.s., not significant. 
†Fisher’s exact test; ‡Mann–Whitney U test. 
 
Table 2 Average costs for medical treatment per patient with polytrauma according to 
type of prehospital care 
  HEMS 
costs (€) 
EMS 
costs (€) 
P* 
Hospital stay (ward) 10 300 10 200 n.s. 
Intensive care stay 16 100 12 400 0.003 
Outpatient clinic 2 400 1 900 n.s. 
Emergency department 1 500 1 500 n.s. 
Surgery 3 400 3 100 n.s. 
Diagnostics 3 600 2 800 0.002 
Rehabilitation/nursing home 1 900 2 600 n.s. 
Total 39 200 34 500 0.016 
HEMS, helicopter emergency medical services; EMS, emergency medical 
servicesn.s., not significant. *Mann–Whitney U test. 
 
 
Table 3 Model of the costs for helicopter emergency medical services per quality-
adjusted life year 
 Regression model 
No. of lives saved 29.0 
Average life expectancy (years)* 38.4 
Total life years gained 1112.5 
QALY saved (utility 0.706) 785.3 
QALY saved after discounting† 434.3 
Total costs for HEMS (€) 12 301 972 
  
Costs per QALY (€) 28 327 
For these calculations the EuroQol – Five Dimensions summary score of 0.706 was used to correct for 
quality of life. *Calculated by using a life expectancy table for the general Dutch population (corrected 
for age and sex): average life expectancy = mean life expectancy in the Netherlands − mean age of 
research population. †Discount rate of 1.5 per cent, as recommended in the Dutch guidelines for 
economic evaluations with t = 38.4. QALY, quality-adjusted life year; HEMS, helicopter emergency 
medical services.  
 
 
